Jiwei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jiwei Liu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Xueming Li
School of Pharmaceutical Science Nanjing Tech University 211816 Nanjing China
8 shared publications - Yan Xu
School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China
7 shared publications Yonglu Wang
School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China
6 shared publicationsKuntang Liu
Nanjing Tech University, School of Pharmaceutical Science and Pharmaceutical Engineering, No. 30 Puzhu South Road, Nanjing 211816, China
5 shared publicationsHao Ren
Nanjing Tech University, School of Pharmaceutical Science and Pharmaceutical Engineering, No. 30 Puzhu South Road, Nanjing 211816, China
4 shared publications- Shan Gao
Key Laboratory of Functional Inorganic Material Chemistry, School of Chemistry and Materials Science, Ministry of Education, Heilongjiang University, Harbin, China
4 shared publications
Latest Publications
- 31 July 2020
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (8) , 9780-9795
Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression
The tumor microenvironment maintains a sufficient immunosuppressive state owing to the existence of the immunosuppressive factors. The most prominent such factor is transforming growth factor β (TGF-β), which is mainly provided by platelets. Moreover, platelets have been shown to be the main accomplice in assisting tumor metastasis. Therefore, blocking tumor-associated platelets is endowed with functions of enhancing immunity and reducing metastasis. Herein, we designed a tumor microenvironment-responsive nitric oxide (NO) release nanoparticle, [email protected], which was able to specifically and safely codeliver the antiplatelet agent NO and the chemotherapeutic agent paclitaxel (Ptx) into tumor tissues, and inhibit platelet-tumor cell interactions. We discovered that [email protected] could successfully block tumor-specific platelet functions, thereby suppressing the process of tumor epithelial-mesenchymal transition (EMT), preventing platelet adhesion around circulating tumor cells (CTCs) and reducing distant metastasis. In vivo studies demonstrate that the codelivery of NO and Ptx can suppress primary tumor growth. With the ability to effectively inhibit activated platelets and TGF-β secretion in tumors, [email protected] can enhance intratumoral immune cell infiltration to reverse the immunosuppressive tumor microenvironment.
- 31 July 2020
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (8) , 9780-9795
Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression
The tumor microenvironment maintains a sufficient immunosuppressive state owing to the existence of the immunosuppressive factors. The most prominent such factor is transforming growth factor β (TGF-β), which is mainly provided by platelets. Moreover, platelets have been shown to be the main accomplice in assisting tumor metastasis. Therefore, blocking tumor-associated platelets is endowed with functions of enhancing immunity and reducing metastasis. Herein, we designed a tumor microenvironment-responsive nitric oxide (NO) release nanoparticle, [email protected], which was able to specifically and safely codeliver the antiplatelet agent NO and the chemotherapeutic agent paclitaxel (Ptx) into tumor tissues, and inhibit platelet-tumor cell interactions. We discovered that [email protected] could successfully block tumor-specific platelet functions, thereby suppressing the process of tumor epithelial-mesenchymal transition (EMT), preventing platelet adhesion around circulating tumor cells (CTCs) and reducing distant metastasis. In vivo studies demonstrate that the codelivery of NO and Ptx can suppress primary tumor growth. With the ability to effectively inhibit activated platelets and TGF-β secretion in tumors, [email protected] can enhance intratumoral immune cell infiltration to reverse the immunosuppressive tumor microenvironment.
- 1 July 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (7) , 2367-2376
Mechanistic Evaluation of the Opposite Effects on Initial Burst Induced by Two Similar Hydrophilic Additives From Octreotide Acetate–Loaded PLGA Microspheres
- 1 July 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (7) , 2367-2376
Mechanistic Evaluation of the Opposite Effects on Initial Burst Induced by Two Similar Hydrophilic Additives From Octreotide Acetate–Loaded PLGA Microspheres
- 4 June 2019
- Published by Springer Nature in Pharmaceutical Research
- Vol. 36 (8) , 1-14
Proton Oriented-“Smart Depot” for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres
Purpose The purpose of this study was to characterize and detail the mechanism of a smart Ca2+ release depot (Ca3(PO4)2) about its ability for sustainable inhibition on peptide acylation within PLGA microspheres. Methods The octreotide acetate release and acylation kinetics were analyzed by RP-HPLC. Changes of Ca2+ concentration and adsorption behavior were determined by a Calcium Colorimetric Assay Kit. The inner pH changes were delineated by a classic pH sensitive probe, Lysosensor yellow/ blue® dextran. Morphological changes of microspheres, adsorption between polymer and additive, transformation of Ca3(PO4)2 were characterized using SEM, FTIR and SSNMR separately. Results Before and after microspheres formulation, the property and effectiveness of Ca3(PO4)2 were investigated. Compared with a commonly used calcium salt (CaCl2), high encapsulation efficiency (96.56%) of Ca3(PO4)2 guarantees lasting effectiveness. In an increasingly acidic environment that simulated polymer degradation, the poorly water-soluble Ca3(PO4)2 could absorb protons and transform into the more and more soluble CaHPO4 and Ca(H2PO4)2 to produce sufficient Ca2+ according to severity of acylation. The corresponding Ca2+ produce capacity fully met the optimum inhibition requirement since the real-time adsorption sites (water-soluble carboxylic acids) inside the degrading microspheres were rare. A sustained retention of three switchable calcium salts and slow release of Ca2+ were observed during the microsphere incubation. FTIR results confirmed the long-term inhibition effect induced by Ca3(PO4)2 on the adsorption between drug and polymer. Conclusions With the presence of the smart Ca2+ depot (Ca3(PO4)2) in the microspheres, a sustainable and long-term inhibition of peptide acylation was achieved.
- 4 June 2019
- Published by Springer Nature in Pharmaceutical Research
- Vol. 36 (8) , 1-14
Proton Oriented-“Smart Depot” for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres
Purpose The purpose of this study was to characterize and detail the mechanism of a smart Ca2+ release depot (Ca3(PO4)2) about its ability for sustainable inhibition on peptide acylation within PLGA microspheres. Methods The octreotide acetate release and acylation kinetics were analyzed by RP-HPLC. Changes of Ca2+ concentration and adsorption behavior were determined by a Calcium Colorimetric Assay Kit. The inner pH changes were delineated by a classic pH sensitive probe, Lysosensor yellow/ blue® dextran. Morphological changes of microspheres, adsorption between polymer and additive, transformation of Ca3(PO4)2 were characterized using SEM, FTIR and SSNMR separately. Results Before and after microspheres formulation, the property and effectiveness of Ca3(PO4)2 were investigated. Compared with a commonly used calcium salt (CaCl2), high encapsulation efficiency (96.56%) of Ca3(PO4)2 guarantees lasting effectiveness. In an increasingly acidic environment that simulated polymer degradation, the poorly water-soluble Ca3(PO4)2 could absorb protons and transform into the more and more soluble CaHPO4 and Ca(H2PO4)2 to produce sufficient Ca2+ according to severity of acylation. The corresponding Ca2+ produce capacity fully met the optimum inhibition requirement since the real-time adsorption sites (water-soluble carboxylic acids) inside the degrading microspheres were rare. A sustained retention of three switchable calcium salts and slow release of Ca2+ were observed during the microsphere incubation. FTIR results confirmed the long-term inhibition effect induced by Ca3(PO4)2 on the adsorption between drug and polymer. Conclusions With the presence of the smart Ca2+ depot (Ca3(PO4)2) in the microspheres, a sustainable and long-term inhibition of peptide acylation was achieved.
- 1 June 2019
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 134, 69-80
Effect of inner pH on peptide acylation within PLGA microspheres
- 1 June 2019
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 134, 69-80
Effect of inner pH on peptide acylation within PLGA microspheres
- 28 March 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (4) , 155
Preparation and Evaluation of Mosapride Citrate Dual-Release Dry Suspension
In this paper, a novel formulation of dual-release dry suspension of mosapride citrate (DRDS-MC) was designed which can be quickly released in the stomach while having sustained-release effect....
- 28 March 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (4) , 155
Preparation and Evaluation of Mosapride Citrate Dual-Release Dry Suspension
In this paper, a novel formulation of dual-release dry suspension of mosapride citrate (DRDS-MC) was designed which can be quickly released in the stomach while having sustained-release effect....
- 22 February 2019
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 11 (12) , 5474-5488
A switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis
Clinical chemotherapy for cancer is limited by the physiological barrier of tumors, resulting in low drug delivery to tumors, poor efficacy of drugs and inability to block tumor metastasis.
- 22 February 2019
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 11 (12) , 5474-5488
A switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis
Clinical chemotherapy for cancer is limited by the physiological barrier of tumors, resulting in low drug delivery to tumors, poor efficacy of drugs and inability to block tumor metastasis.
- 21 September 2018
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 30 (1) , 143-152
Acetate chitosan with CaCO3 doping form tough hydrogel for hemostasis and wound healing
In recent years, chitosan has been applied for wound management due to its properties of biocompatibility, biodegradability, antimicrobial activity, and low immunogenicity. But the poor water solubility in neutral pH limited its further application in clinical wound healing. To overcome this problem, acetate chitosan was developed and approved as commercial products for wound healing. However, the acidity of acetate chitosan was potentially allergenic, and the poor mechanical properties of its formed hydrogels also hindered the therapeutic efficacy in wound care. In this study, CaCO3 was simply doped into acetate chitosan to form the wound dressing. After absorbing water, the H+ of acetate chitosan reacted with CaCO3 to release Ca2+, resulting in acidity decreased. The production of Ca2+ and residue of CaCO3 cross‐linked with chitosan to form a tough hydrogel by electrostatic interaction. The physical characteristics, swelling, mechanical testing, and blood clotting were evaluated. The results in vitro demonstrated that after doping CaCO3 into acetate chitosan, the mechanical properties and blood clotting of the formed hydrogel were increased. Then, the evaluation of hydrogels in vivo revealed that it can also accelerate the wound healing by promoting re‐epithelization and collagen deposition. This simple way by doping CaCO3 into acetate chitosan can increase wound healing, and it can also broad the application of acetate chitosan in clinical use.
- 21 September 2018
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 30 (1) , 143-152
Acetate chitosan with CaCO3 doping form tough hydrogel for hemostasis and wound healing
In recent years, chitosan has been applied for wound management due to its properties of biocompatibility, biodegradability, antimicrobial activity, and low immunogenicity. But the poor water solubility in neutral pH limited its further application in clinical wound healing. To overcome this problem, acetate chitosan was developed and approved as commercial products for wound healing. However, the acidity of acetate chitosan was potentially allergenic, and the poor mechanical properties of its formed hydrogels also hindered the therapeutic efficacy in wound care. In this study, CaCO3 was simply doped into acetate chitosan to form the wound dressing. After absorbing water, the H+ of acetate chitosan reacted with CaCO3 to release Ca2+, resulting in acidity decreased. The production of Ca2+ and residue of CaCO3 cross‐linked with chitosan to form a tough hydrogel by electrostatic interaction. The physical characteristics, swelling, mechanical testing, and blood clotting were evaluated. The results in vitro demonstrated that after doping CaCO3 into acetate chitosan, the mechanical properties and blood clotting of the formed hydrogel were increased. Then, the evaluation of hydrogels in vivo revealed that it can also accelerate the wound healing by promoting re‐epithelization and collagen deposition. This simple way by doping CaCO3 into acetate chitosan can increase wound healing, and it can also broad the application of acetate chitosan in clinical use.
- 22 March 2013
- Published by Tsinghua University Press in Nano Research
- Vol. 6 (4) , 275-285
Uniform wurtzite MnSe nanocrystals with surface-dependent magnetic behavior
Manganese selenide (MnSe) possesses unique magnetic properties as an important magnetic semiconductor, but the synthesis and properties of MnSe nanocrystals are less developed compared to other semiconductor nanocrystals because of the inability to obtain high-quality MnSe, especially in the metastable wurtzite structure. Here, we have successfully fabricated wurtzite MnSe nanocrystals via a colloidal approach which affords uniform crystal sizes and tailored shapes. The selective binding strength of the amine surfactant is the determining factor in shape-control and shape-evolution. Bullet-shapes could be transformed into shuttle-shapes if part of the oleylamine in the reaction solution was replaced by trioctylamine, and tetrapod-shaped nanocrystals could be formed in trioctylamine systems. The three-dimensional (3D) structure of the bullet-shaped nanorods has been demonstrated by the advanced transmission electron microscope (TEM) 3D-tomography technology. High-resolution TEM (HRTEM) and electron energy-loss spectroscopy (EELS) show that planar-defect structures such as stacking faults and twinning along the [001] direction arise during the growth of bullet-shapes. On the basis of careful HRTEM observations, we propose a “quadra-twin core” growth mechanism for the formation of wurtzite MnSe nanotetrapods. Furthermore, the wurtzite MnSe nanocrystals show lowtemperature surface spin-glass behavior due to their noncompensated surface spins and the blocking temperatures increase from 8.4 K to 18.5 K with increasing surface area/volume ratio of the nanocrystals. Our results provide a systematic study of wurtzite MnSe nanocrystals.
- 22 March 2013
- Published by Tsinghua University Press in Nano Research
- Vol. 6 (4) , 275-285
Uniform wurtzite MnSe nanocrystals with surface-dependent magnetic behavior
Manganese selenide (MnSe) possesses unique magnetic properties as an important magnetic semiconductor, but the synthesis and properties of MnSe nanocrystals are less developed compared to other semiconductor nanocrystals because of the inability to obtain high-quality MnSe, especially in the metastable wurtzite structure. Here, we have successfully fabricated wurtzite MnSe nanocrystals via a colloidal approach which affords uniform crystal sizes and tailored shapes. The selective binding strength of the amine surfactant is the determining factor in shape-control and shape-evolution. Bullet-shapes could be transformed into shuttle-shapes if part of the oleylamine in the reaction solution was replaced by trioctylamine, and tetrapod-shaped nanocrystals could be formed in trioctylamine systems. The three-dimensional (3D) structure of the bullet-shaped nanorods has been demonstrated by the advanced transmission electron microscope (TEM) 3D-tomography technology. High-resolution TEM (HRTEM) and electron energy-loss spectroscopy (EELS) show that planar-defect structures such as stacking faults and twinning along the [001] direction arise during the growth of bullet-shapes. On the basis of careful HRTEM observations, we propose a “quadra-twin core” growth mechanism for the formation of wurtzite MnSe nanotetrapods. Furthermore, the wurtzite MnSe nanocrystals show lowtemperature surface spin-glass behavior due to their noncompensated surface spins and the blocking temperatures increase from 8.4 K to 18.5 K with increasing surface area/volume ratio of the nanocrystals. Our results provide a systematic study of wurtzite MnSe nanocrystals.
- 4 December 2004
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Structure Reports Online
- Vol. 61 (1) , m33-m35
catena-Poly[[[tetraaquacobalt(II)]-μ-4,4′-bipyridine-κ2N:N′] 3-carboxylatophenoxyacetate monohydrate]
- 4 December 2004
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Structure Reports Online
- Vol. 61 (1) , m33-m35
catena-Poly[[[tetraaquacobalt(II)]-μ-4,4′-bipyridine-κ2N:N′] 3-carboxylatophenoxyacetate monohydrate]